<DOC>
	<DOC>NCT00716859</DOC>
	<brief_summary>To assess the effectiveness of latanoprost 0.005% ophthalmic solution dosed once-daily and timolol 0.5% dosed twice-daily in paediatric subjects of 18 years of age or under who are diagnosed with glaucoma.</brief_summary>
	<brief_title>A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma.</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<criteria>Male or female of 18 years of age or under Diagnosis of glaucoma IOP of 22 mmHg or above in at least 1 eye Require surgery for acute angle closure Have had prior cyclodestructive procedures Have a history of ocular trauma or surgery in either eye within 3 months of the baseline visit</criteria>
	<gender>All</gender>
	<minimum_age>36 Weeks</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>